全文获取类型
收费全文 | 1795篇 |
免费 | 89篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 21篇 |
妇产科学 | 24篇 |
基础医学 | 150篇 |
口腔科学 | 42篇 |
临床医学 | 142篇 |
内科学 | 343篇 |
神经病学 | 416篇 |
特种医学 | 70篇 |
外国民族医学 | 2篇 |
外科学 | 380篇 |
综合类 | 23篇 |
一般理论 | 1篇 |
预防医学 | 70篇 |
眼科学 | 14篇 |
药学 | 54篇 |
中国医学 | 3篇 |
肿瘤学 | 116篇 |
出版年
2023年 | 23篇 |
2022年 | 27篇 |
2021年 | 50篇 |
2020年 | 38篇 |
2019年 | 37篇 |
2018年 | 30篇 |
2017年 | 50篇 |
2016年 | 33篇 |
2015年 | 33篇 |
2014年 | 55篇 |
2013年 | 78篇 |
2012年 | 118篇 |
2011年 | 99篇 |
2010年 | 64篇 |
2009年 | 55篇 |
2008年 | 96篇 |
2007年 | 102篇 |
2006年 | 102篇 |
2005年 | 81篇 |
2004年 | 74篇 |
2003年 | 74篇 |
2002年 | 86篇 |
2001年 | 69篇 |
2000年 | 65篇 |
1999年 | 66篇 |
1998年 | 16篇 |
1997年 | 10篇 |
1996年 | 8篇 |
1995年 | 8篇 |
1994年 | 6篇 |
1993年 | 9篇 |
1992年 | 22篇 |
1991年 | 33篇 |
1990年 | 16篇 |
1989年 | 26篇 |
1988年 | 21篇 |
1987年 | 28篇 |
1986年 | 13篇 |
1985年 | 9篇 |
1984年 | 9篇 |
1983年 | 3篇 |
1981年 | 3篇 |
1979年 | 3篇 |
1976年 | 3篇 |
1975年 | 3篇 |
1974年 | 3篇 |
1972年 | 3篇 |
1968年 | 2篇 |
1967年 | 6篇 |
1966年 | 2篇 |
排序方式: 共有1886条查询结果,搜索用时 15 毫秒
991.
Human cytomegalovirus (HCMV) has been proposed as an amplifying agent for at least some of the spectrum of systemic sclerosis (SSc; scleroderma). In support of this hypothesis, antibodies to the HCMV late protein UL94 have been detected in the majority of SSc patients in a study involving Caucasian subjects from Italy. The aim of this investigation was to determine whether elevated levels of anti-UL94 antibodies are present in African American and Caucasian SSc patients from the U.S. We further wished to determine whether there was a significant difference in the levels of anti-UL94 antibodies between the diffuse and the limited forms of the disease. IgG antibodies to a UL94 peptide were measured in 254 Caucasian and 90 African American subjects by an enzyme-linked immunosorbent assay (ELISA). In both Caucasian and African American subjects, the mean antibody level in the diffuse form of SSc was significantly higher than that in the respective control subjects (714 vs. 466?ng/ml, p=0.005; 1226 vs. 512?ng/ml, p<0.0001). Also, among Caucasian SSc patients, the mean antibody level in the diffuse form of SSc was significantly higher than that in the limited form of the disease (714 vs. 465?ng/ml, p=0.02). These results show that increased levels of antibodies to the HCMV late protein UL94 are associated with SSc and they may be a marker for the severity of the disease. 相似文献
992.
La Rocca Marianna Barisano Giuseppe Bennett Alexis Garner Rachael Engel Jerome Gilmore Emily J. McArthur David L. Rosenthal Eric Stanis James Vespa Paul Willyerd Frederick Zimmermann Lara L. Toga Arthur W. Duncan Dominique 《Brain imaging and behavior》2021,15(6):2804-2812
Brain Imaging and Behavior - Traumatic brain injury (TBI) can produce heterogeneous injury patterns including a variety of hemorrhagic and non-hemorrhagic lesions. The impact of lesion size,... 相似文献
993.
Daher René Ardu Stefano Di Bella Enrico Rocca Giovanni T. Feilzer Albert J. Krejci Ivo 《Odontology / the Society of the Nippon Dental University》2021,109(2):368-375
Odontology - The purpose of this in-vitro study was to evaluate the fracture resistance and failure mode of non-invasively reinforced endodontically treated mandibular molars. Sixty freshly... 相似文献
994.
In 1994-1995, a screening and examination survey was conducted to ascertain the prevalence of dementia, Parkinson's disease and stroke in two urban communities and one rural community of central Spain. We use this survey to illustrate many nonclinical aspects of conducting two-phase prevalence surveys. Special emphasis is given to two common weaknesses in such surveys: screening nonparticipation and screening validation. 相似文献
995.
E. Rota G. Bellone P. Rocca B. Bergamasco G. Emanuelli P. Ferrero 《Neurological sciences》2006,27(1):33-39
Abstract An inflammatory response has been hypothesised to be involved in the pathogenesis of primary dementias, above all Alzheimer’s
disease (AD). This study was aimed at evaluating interleukin (IL)-12 and a panel of related cytokine levels in paired CSF
and sera of demented patients. IL-12 (p70 heterodimer and total IL-12 p40 chain), interferon (IFN)-γ, IL-10 and transforming
growth factor (TGF)-β1 levels were measured in 30 patients with probable Alzheimer’s disease (PrAD), 57 patients with other
dementing disorders, including probable vascular dementia (PrVD), Parkinson’s disease (PD) and normal pressure hydrocephalus
(NPH), and 25 cognitively normal control subjects. In the presence of unchanged concentrations of IL-12, IFN-γ and IL-10,
the mean CSF level of TGF-β1 and the correspondent TGF-β1 index, but not the serum level, were significantly increased in
PrAD compared to controls and PrVD, whereas no difference was found vs. NPH and PD. Our results support the pathophysiological
role of TGF-β1 system in AD. 相似文献
996.
Advances in superporous hydrogels. 总被引:11,自引:0,他引:11
Superporous hydrogels (SPHs) are different from superabsorbent polymers (SAPs) in that SPHs swell fast, within minutes, to the equilibrium swollen state regardless of their size. The fast swelling property is based on water absorption through open porous structure by capillary force. The poor mechanical strength of SPHs was overcome by developing the second-generation SPH composites (SPHCs) and the third-generation SPH hybrids (SPHHs). This review examines the differences between SAPs and SPHs and describes three different generations of SPHs. 相似文献
997.
Michael J Zellweger Christoph Kaiser Hans Peter Brunner-La Rocca Peter T Buser Stefan Osswald Philipp Weiss Jan Mueller-Brand Matthias E Pfisterer 《Journal of nuclear medicine》2008,49(4):550-556
Drug-eluting stents reduce clinical events related to restenosis but may be complicated by late stent-thrombosis. Whereas assessment of target-vessel ischemia by myocardial perfusion scintigraphy identifies relevant restenosis noninvasively, it is unknown whether this technique may also predict late clinical events related to late stent-thrombosis and to restenosis after drug-eluting stent implantation. METHODS: All 826 patients treated with stenting between May 2003 and May 2004 were included in the Basel Stent Cost Effectiveness Trial (Basel Stent Kosten-Effektivit?ts Trial, or BASKET) and randomized (2:1) to drug-eluting stents or bare metal stents. Myocardial scintigraphy was performed on 476 (64%) of 747 patients without major events after 6 mo. Patients were followed for 1 y for cardiac death, nonfatal myocardial infarction, and target-vessel revascularization due to restenosis or late stent-thrombosis. RESULTS: The rate of target-vessel ischemia in these patients was lower with drug-eluting stents than with bare metal stents (5.4% vs. 10.4%, P = 0.045), similar to the rates of symptom-driven target-vessel revascularization up to 6 mo (4.6% vs. 7.8%, P = 0.08). Ischemia was silent in 68%. During follow-up, patients with target-vessel ischemia had higher event rates than did patients without ischemia (32.4% vs. 6.1%, P < 0.001); however, ischemia did not predict late stent-thrombosis (0/11 cases). CONCLUSION: The rate of clinical restenosis assessed scintigraphically was lower with drug-eluting stents than with bare metal stents and paralleled that of symptom-driven target-vessel revascularization. Target-vessel ischemia independently predicted late clinical events related to restenosis but not to late stent-thrombosis. 相似文献
998.
W A Rocca G Savettieri D W Anderson F Meneghini F Grigoletto L Morgante A Reggio G Salemi F Patti R Di Perri 《Neuroepidemiology》2001,20(4):237-241
A door-to-door prevalence survey of epilepsy was conducted in 3 Sicilian municipalities, as of November 1, 1987. In phase 1, the screening by questionnaire of 24,496 eligible subjects (participation = 92%) identified 544 suspected to have epilepsy. In phase 2, neurological evaluation of the 544 subjects yielded 111 with epilepsy. Of the 111 subjects, 103 (93%) had been previously diagnosed, 68 (61%) were taking antiepileptic medication, and 81 (73%) had active epilepsy. Referring to the 81 subjects with active epilepsy, the seizure type was generalized in 60 (74%), partial in 19 (23%) and undetermined in 2 (3%). The prevalence of active epilepsy (per 1,000 population) was 3.3 overall, 3.5 for men and 3.2 for women. The age-specific patterns for active epilepsy differed by sex, with higher figures for men at younger ages (5-19 years) and older ages (50-99 years). The age-specific prevalence figures for active epilepsy were lower than those from previous Italian surveys. 相似文献
999.
Michael W M Schüpbach Marie Laure Welter Anne Marie Bonnet Alexis Elbaz Brandon R Grossardt Valerie Mesnage Jean Luc Houeto David Maltête Luc Mallet Walter A Rocca Alain Mallet Yves Agid 《Movement disorders》2007,22(2):257-261
Subthalamic nucleus (STN) stimulation improves motor disability and quality of life in patients with advanced Parkinson's disease (PD). Short-term mortality is low, but little is known about long-term mortality. We assessed mortality and causes of death in 171 consecutive PD patients treated by STN stimulation. Surgery was performed after a median lagtime of 13 years from PD onset at a median age of 57 years. The median follow-up after surgery was 41 months. Sixteen patients died 8 to 83 months after neurosurgery. Poorer cognitive function was the only predictive factor for mortality (standardized mortality ratio = 2.9; 95% confidence interval [CI], 1.6-4.7; P < 0.0001). Based on a historical comparison of 118 operated patients with 39 nonoperated patients from a different population, survival among operated patients was not better (hazard ratio = 1.2; 95% CI, 0.7-2.1). 相似文献
1000.